Log In
Print this Print this

dexamethasone (DexaSite) (ISV-305)

  Manage Alerts
Collapse Summary General Information
Company Sun Pharmaceutical Industries Ltd.
DescriptionDexamethasone corticosteroid in InSite's DuraSite ophthalmic drug delivery system
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase III
Standard Indication Ophthalmic (unspecified)
Indication DetailsTreat blepharitis; Treat non-bacterial blepharitis; Treat ocular inflammation
Regulatory Designation U.S. - Special Protocol Assessment (Treat blepharitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments





 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today